A Phase 1 Study Comparing AVP-786 With AVP-923

NCT02336347 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: AVP-786
DRUG: AVP-923

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.